Role of PKCε in PGF2α-stimulated MMP-2 secretion from human ciliary muscle cells

Journal of Ocular Pharmacology and Therapeutics

Volumn 24, Issue 3, 2008, Pages 268-277

  Husain, Shahid ^a,b   Crosson, Craig E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; CHELERYTHRINE; GELATINASE A; GLUTAMYLALANYLVALYLSERYLLEUCYLLYSYLPROLYLTHREONINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN F2 ALPHA; PROTEIN ANTIBODY; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C IOTA; PROTEIN KINASE C LAMBDA; SMALL INTERFERING RNA; BENZOPHENANTHRIDINE DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL FUNCTION; CELL MEMBRANE; CILIARY MUSCLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MUSCLE CELL; SERUM; UPREGULATION; WESTERN BLOTTING; ADULT; AGED; CILIARY BODY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; IN VITRO STUDY; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROTEIN TRANSPORT; SMOOTH MUSCLE;

ADULT; AGED; BENZOPHENANTHRIDINES; CILIARY BODY; DINOPROST; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; INDICATORS AND REAGENTS; ISOENZYMES; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; MUSCLE, SMOOTH; PROTEIN KINASE C-EPSILON; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 44349176790     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0014     Document Type: Article

References (48)

1. Abramovitz, M., Boie, Y., Nguyen, T., et al. Cloning and expression of a cDNA for the human prostanoid FP receptor. J. Biol. Chem. 269:2632-2636, 1994.
2. Sugimoto, Y., Hasumoto, K., Namba, T., et al. Cloning and expression of a cDNA for mouse prostaglandin F receptor. J. Biol. Chem. 269:1356-1360, 1994.
3. Sakamoto, K., Ezashi, T., Miwa, K., et al. Molecular cloning and expression of a cDNA of the bovine prostaglandin F2-alpha receptor. J. Biol. Chem. 269: 3881-3886, 1994.
4. Husain, S., Kaddour-Djebbar, I., and Abdel-Latif, A.A. Alterations in arachidonic acid release and phospholipase C-beta(1) expression in glaucomatous human ciliary muscle cells. Invest. Ophthalmol. Vis. Sci. 43:1127-1134, 2002.
5. Sharif, N.A., Crider, J.Y., Husain, S., et al. Human ciliary muscle cell responses to FP-class prostaglandin analogs: Phosphoinositide hydrolysis, intracellular Ca(2+) mobilization, and MAP-kinase activation. J. Ocul. Pharmacol. Ther. 19:437-455, 2003.
6. Toh, H., Ichikawa, A., and Narumiya, S. Molecular evolution of receptors for eicosanoids. FEBS Lett. 361:17-21, 1995.
7. Adams, J.W., Migita, D.S., Yu, M.K., et al. Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J. Biol. Chem. 271:1179-1186, 1996.
8. Giuffre, G. The effects of prostaglandin F2 alpha in the human eye. Graefe's Arch. Clin. Exp. Ophthalmol. 222:139-141, 1985.
9. Horton, E.W., and Poyser, N.L. Uterine luteolytic hormone: A physiological role for prostaglandin F2-alpha. Physiol. Rev. 56:595-651, 1976.
10. McCracken, J.A., Glew, M.E., Scaramuzzi, R.J. Corpus luteum regression induced by prostagland in F2-alpha. J. Clin. Endocrinol. Metab. 30:544-546, 1970.
11. Hellberg, M.R., Sallee, V.L., McLaughlin, M.A., et al. Preclinical efficacy of travoprost, a potent and selective FP-prostaglandin-receptor agonist. J. Ocul. Pharmacol. Ther. 17:421-432, 2001.
12. Alm, A., and Stjernschantz, J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once-daily, evening, or morning. A comparison with timolol. The Scandinavian Latanoprost Study Group. Ophthalmology 102:1743-1752, 1995.
13. Stjernschantz, J., Selen, G., Sjoquist, B., et al. Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2-alpha analogue. Adv. Prostagl. Thrombox. Leukot. Res. 23:513-518, 1995.
14. Bito, L.Z., Stjernschantz, J., Resul, B., et al. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management. J. Lipid Mediat. 6:535-543, 1993.
15. Crawford, K., and Kaufman, P.L. Pilocarpine antagonizes prostaglandin F2-alpha-induced ocular hypotension in monkeys. Evidence for enhancement of uveoscleral outflow by prostaglandin F2 alpha. Arch. Ophthalmol. 105:1112-1116, 1987.
16. Gabelt, B.T., and Kaufman, P.L. Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey. Exp. Eye Res. 49:389-402, 1989.
17. Lindsey, J.D., Kashiwagi, K., Kashiwagi, F., et al. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: Implications for uveoscleral outflow. Surv. Ophthalmol. 41:S53-S59, 1997.
18. Lindsey, J.D., Kashiwagi, K., Kashiwagi, F., et al. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest. Ophthalmol. Vis. Sci. 38:2214-2223, 1997.
19. Lutjen-Drecoll, E., and Tamm, E. Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2 alpha. Exp. Eye Res. 47:761-769, 1988.
20. Nilsson, S.F., Samuelsson, M., Bill, A., et al. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2-alpha-1-isopropylester in the cynomolgus monkey. Exp. Eye Res. 48:707-716, 1989.
21. Bradley, J.M., Vranka, J., Colvis, C.M., et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest. Ophthalmol. Vis. Sci. 39:2649-2658, 1998.
22. Crosson, C.E., Sloan, C.F., and Yates, P.W. Modulation of conventional outflow facility by the adenosine A1 agonist N6-cyclohexyladenosine. Invest. Ophthalmol. Vis. Sci. 46:3795-3799, 2005.
23. Lindsey, J.D., Kashiwagi, K., Boyle, D., et al. Prostaglandins increase pro-MMP-1 and pro-MMP-3 secretion by human ciliary smooth muscle cells. Curr. Eye Res. 15:869-875, 1996.
24. Alexander, J.P., Samples, J.R., and Acott, T.S. Growth-factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr. Eye Res. 17:276-285, 1998.
25. Alexander, J.P., Samples, J.R., Van Buskirk, E.M., et al. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 32:172-180, 1991.
26. Sagara, T., Gaton, D.D., Lindsey, J.D., et al. Reduction of collagen type I in the ciliary muscle of inflamed monkey eyes. Invest. Ophthalmol. Vis. Sci. 40:2568-2576, 1999.
27. Shearer, T.W., and Crosson, C.E. Adenosine A1 receptor modulation of MMP-2 secretion by trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 43:3016-3020, 2002.
28. Husain, S., Jafri, F., and Crosson, C.E. Acute effects of PGF2-alpha on MMP-2 secretion from human ciliary muscle cells: A PKC- and ERK-dependent process. Invest. Ophthalmol. Vis. Sci. 46:1706-1713, 2005.
29. Husain, S., Young, D., and Wingard, C.J. Role of PKC-alpha and PKC-iota in phenylephrine-induced contraction of rat corpora cavernosa. Int. J. Impot. Res. 16:325-333, 2004.
30. Morris, M.C., Depollier, J., Mery, J., et al. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19:1173-1176, 2001.
31. Elbashir, S.M., Harborth, J., Lendeckel, W., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498, 2001.
32. Schulte, G., and Fredholm, B.B. Diverse inhibitors of intracellular signalling act as adenosine receptor antagonists. Cell Signal 14:109-113, 2002.
33. Ko, F.N., Chen, I.S., Wu, S.J., et al. Antiplatelet effects of chelerythrine chloride isolated from Zanthoxylum simulans. Biochim. Biophys. Acta 1052:360-365, 1990.
34. Lenfeld, J., Kroutil, M., Marsalek, E., et al. Anti-inflammatory activity of quaternary benzophenanthridine alkaloids from Chelidonium majus. Planta Med. 43:161-165, 1981.
35. Yu, R., Mandlekar, S., Tan, T.H., et al. Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C. J. Biol. Chem. 275: 9612-9619, 2000.
36. Hug, H., and Sarre, T.F. Protein kinase C isoenzymes: Divergence in signal transduction? Biochem. J. 291: 329-343, 1993.
37. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614, 1992.
38. Khurana, N., Deng, P.F., Epstein, D.L., et al. The role of protein kinase C in modulation of aqueous humor outflow facility. Exp. Eye Res. 76:39-47, 2003.
39. Thieme, H., Nass, J.U., Nuskovski, M., et al. The effects of protein kinase C on trabecular meshwork and ciliary muscle contractility. Invest. Ophthalmol. Vis. Sci. 40:3254-3261, 1999.
40. Tian, B., Brumback, L.C., and Kaufman, P.L. ML-7, chelerythrine, and phorbol ester increase outflow facility in the monkey eye. Exp. Eye Res. 71:551-566, 2000.
41. Huang, X., and Walker, J.W. Myofilament anchoring of protein kinase C-epsilon in cardiac myocytes. J. Cell Sci. 117:1971-1978, 2004.
42. Johnson, J.A., Gray, M.O., Chen, C.H., et al. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J. Biol. Chem. 271: 24962-24966, 1996.
43. Louis, K., Guerineau, N., Fromigue, O., et al. Tumor-cell-mediated induction of the stromal factor stromelysin-3 requires heterotypic cell contact-dependent activation of specific protein kinase C isoforms. J. Biol. Chem. 280:1272-1283, 2005.
44. McDonnell, S.E., Kerr, L.D., and Matrisian, L.M. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of protooncogenes c-fos and c-jun and activation of protein kinase C. Mol. Cell. Biol. 10:4284-4293, 1990.
45. Alexander, J.P., and Acott, T.S., Involvement of protein kinase C in TNFα regulation of trabecular matrix metalloproteinases and TIMPs. Invest. Ophthalmol. Vis. Sci. 42:2831-2838, 2001.
46. Fleenor, D.L., Pang, I.H., and Clark, A.F. Involvement of AP-1 in interleukin-1-alpha-stimulated MMP-3 expression in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 44:3494-3501, 2003.
47. Anthony, T.L., Lindsey, J.D., and Weinreb, R.N. Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. Invest. Ophthalmol. Vis. Sci. 43:3705-3711, 2002.
48. Weinreb, R.N., Kashiwagi, K., Kashiwagi, F., et al. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest. Ophthalmol. Vis. Sci. 38:2772-2780, 1997.